• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.59% Nasdaq Up0.27%

    More On GENE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Genetic Technologies Limited (GENE)

    -NasdaqCM
    0.36 Down 0.01(1.84%) 1:30PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):3.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:2.50
    Median Target:2.50
    High Target:2.50
    Low Target:2.50
    No. of Brokers:1

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 13, 2014Ladenburg ThalmannUpgradeNeutralBuy
    May 3, 2013Ladenburg ThalmannUpgradeSellNeutral
    Nov 16, 2012Ladenburg ThalmannDowngradeBuySell
    Nov 30, 2011Ladenburg ThalmannInitiated Buy
    Jun 2, 2004First AlbanyInitiated Strong Buy
    Apr 15, 2004Legg MasonInitiated Buy
    Jan 27, 2004FulcrumInitiated Buy
    Jun 18, 2001Friedman BillingsUpgradeMkt PerformAccumulate
    May 25, 2001Friedman BillingsDowngradeAccumulateMkt Perform
    May 23, 2001Ladenburg ThalmannInitiated NT/LT Strong Buy

    More Upgrades & Downgrades for GENE

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0001
    Buy0000
    Hold0110
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.